The use of cocaine and MDMA has fallen in Queensland since COVID-19 disruptions began in 2020, but the use of methylamphetamine or ‘ice’ has increased according to a report from Australian Criminal Intelligence Commission (ACIC).
26 October 2022
University of Queensland researchers have discovered how COVID-19 damages the heart, opening the door to future treatments.
30 September 2022
Global biopharmaceutical company Pfizer has acquired University of Queensland startup ResApp Health Limited for $179 million.
27 September 2022
Radiopharmaceuticals are an emerging medical technology that deliver radiation therapy directly to cancer cells while sparing the rest of the body from the harsh effects of cancer treatment.
13 September 2022
Researchers at The University of Queensland are seeking volunteer school rugby and basketball players for brain scans as they work on a new blood test to help diagnose concussion.
31 August 2022
Australia’s first dedicated children’s immunotherapy centre will investigate treatments to increase the survival of kids with cancer and improve their ongoing quality of life.
24 August 2022
Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold.
14 July 2022
A skin microbiopsy device developed by researchers at The University of Queensland, that takes tissue samples smaller than 0.5mm in diameter, could change the way skin cancers and other skin conditions are diagnosed and monitored.
19 April 2022
When clinical psychiatrist and University of Queensland researcher Dr Cathy Franklin saw her first patient with Catatonia and Acute Regression in Down Syndrome in 2009, she was shocked.
22 March 2022
Researchers at The University of Queensland have developed a mathematical model that can predict the efficacy of COVID-19 vaccines, potentially speeding-up the development of new vaccines.
15 March 2022
The University of Queensland has been selected as one of the first launch institutions in the world to partner with biotechnology company Moderna to research and develop vaccines to tackle the world’s greatest global public health threats.
10 March 2022
